Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/ebzZCfbwoceVjAfNtSVy

December 7, 2012
Sign upForwardArchiveAdvertise
News for physicians caring for the seriously ill

  Top Story 
 
  • Study considers whether to give IV fluids to patients near death
    A recent study sheds some light on whether IV or subcutaneous fluids should be avoided at the end of life to prevent fluid buildup and if doing so leads to delirium, Dr. Eric Widera writes. Research in the Journal of Clinical Oncology found no significant differences between patients with IV hydration and without in terms of dehydration symptoms or overall delirium scores. The study included 129 patients with mild to moderate but not severe dehydration. GeriPal blog (12/5) LinkedInFacebookTwitterEmail this Story
100% Online MBA in Health Care Management – Leadership & General Management
Marylhurst University's online MBA in Health Care Management with the Leadership & General Management concentration is designed for health care and other business professionals who seek additional education to help them effectively lead teams and advance management careers throughout the health care industry. Learn more about how you can get started.

  Palliative & Hospice Care Update  
  • Targeted therapy may delay end-of-life transition, study finds
    Targeted therapies such as bevacizumab, erlotinib, sorafenib and rituximab are increasingly are used in advanced cancer patients at the end of life, according to research from the University of Texas MD Anderson Cancer Center. The study team wrote in the Journal of Pain and Symptom Management these treatments are used about as often as chemotherapy and could delay a transition in care, "diverting patients' precious time and energy to the pursuit of cancer treatments rather than planning ahead." MedWire News (U.K.) (12/6) LinkedInFacebookTwitterEmail this Story
  • Other News
The Key To Positive Cash Flow
Every business is cyclical with cash flow ups and downs. The key is to find a way to keep the cash coming in as predictably as possible. Seem impossible? Well it's not. There are systems and processes that make it easier to collect the cash you've earned so your small business can grow. Learn how these small-business owners set up their businesses for success.

  Patient & Family Perspective  
 
  • Other News
How SDN Makes Campus Networks Better
When should agencies adopt SDN? IDC reports that SDN provides immediate benefits for government campus networks, including modernized IT infrastructures that are more agile, cost-effective, and collaborative.
Read this new IDC paper to learn more.

  Medical Research  
  • Positive attitude toward pain increases tolerance, study says
    An Italian study found patients who had a positive or beneficial approach to pain had higher tolerances. The study, reported in the journal Pain, highlights the importance of the meaning of pain in patients' perception of it. "Therefore, the behavioral and/or pharmacological manipulation of the meaning of pain can represent an effective approach to pain management," a researcher wrote. MedWire News (U.K.) (12/5) LinkedInFacebookTwitterEmail this Story
  • 10 years of tamoxifen better to prevent breast cancer, study finds
    Women using tamoxifen to prevent a recurrence of breast cancer had better protection if they took the drug for 10 years instead of the standard five, Oxford University researchers reported in The Lancet. Breast cancer experts said the data, which showed a lower recurrence rate among women who took the drug longer, also may have implications for postmenopausal women who usually take other medications to prevent a recurrence. The New York Times (tiered subscription model) (12/5) LinkedInFacebookTwitterEmail this Story
  Health Policy & Practice  
  • FDA expresses confidence in reviews of generic drugs
    The FDA's approval process for generic drugs, including approvals based on extrapolated data, is safe and reliable, Center for Drug Evaluation and Research Director Dr. Janet Woodcock and other FDA officials wrote in an article in the New England Journal of Medicine. The agency withdrew approval for 300-milligram bupropion after finding it did not perform similarly to the 150-mg dose upon which approval was based. Medscape (free registration) (12/5) LinkedInFacebookTwitterEmail this Story
  Trends & Technology  
  • Platform allows patient monitoring via live video chat
    AT&T has unveiled a cloud-based remote patient-monitoring platform designed to enable physicians to better monitor their patients' chronic conditions, including diabetes, via video chat. Video chatting may allow clinicians to observe signs of problems such as mood and skin color changes that they would not be able to note through a phone conversation, according to an AT&T official. eWeek (12/5) LinkedInFacebookTwitterEmail this Story
  AAHPM News  
  • Are you following best practices in your billing and coding?
    Participate in this webinar, sponsored by the American Academy of Hospice and Palliative Medicine on Dec. 11 at 2 p.m. Eastern Time and learn the best practices in billing and coding for providers in hospice and palliative care, as well as what triggers a billing audit, the difference between billing by time versus complexity, the basics of billing and coding and common pitfalls, and the importance of having a compliance program. LinkedInFacebookTwitterEmail this Story
  • Opioid REMS and safe use practices: What are the implications today?
    Learn about risk evaluation and mitigation strategies associated with long-acting and extended-release opioids. This online activity, developed by CO*RE, in partnership with Medscape, offers CME/CE credit for learners. No fee required. Learn more. LinkedInFacebookTwitterEmail this Story
  SmartQuote  
You will never find time for anything. If you want time you must make it."
--Charles Buxton,
British brewer, philanthropist, writer and legislator


LinkedInFacebookTwitterEmail this Story

 
This newsletter is brought to you by the American Academy of Hospice and Palliative Medicine and SmartBrief.
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Senior Account Director:  Aaron Kern 202-407-7866
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent Hospice and Palliative Medicine SmartBrief Issues:   Lead Editor:  Tom Parks
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2012 SmartBrief, Inc.® Legal Information